IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Phase 2 biotech developing therapies for cancer.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/29/2023 |
Offer Price | |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $4.00 - $4.00 | |
Offer Shares (mm) | 1.6 |
Deal Size ($mm) | $6 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Boustead Securities |
Company Data | |
---|---|
Headquarters | Los Angeles, CA, United States |
Founded | 2013 |
Employees | 3 |
Website www.kairospharma.com |